Literature DB >> 11447277

Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons.

Y Huang1, X Q Liu, T Wyss-Coray, W J Brecht, D A Sanan, R W Mahley.   

Abstract

Human apolipoprotein (apo) E4, a major risk factor for Alzheimer's disease (AD), occurs in amyloid plaques and neurofibrillary tangles (NFTs) in AD brains; however, its role in the pathogenesis of these lesions is unclear. Here we demonstrate that carboxyl-terminal-truncated forms of apoE, which occur in AD brains and cultured neurons, induce intracellular NFT-like inclusions in neurons. These cytosolic inclusions were composed of phosphorylated tau, phosphorylated neurofilaments of high molecular weight, and truncated apoE. Truncated apoE4, especially apoE4(Delta 272--299), induced inclusions in up to 75% of transfected neuronal cells, but not in transfected nonneuronal cells. ApoE4 was more susceptible to truncation than apoE3 and resulted in much greater intracellular inclusion formation. These results suggest that apoE4 preferentially undergoes intracellular processing, creating a bioactive fragment that interacts with cytoskeletal components and induces NFT-like inclusions containing phosphorylated tau and phosphorylated neurofilaments of high molecular weight in neurons.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447277      PMCID: PMC37522          DOI: 10.1073/pnas.151254698

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  The molecular pathology of Alzheimer's disease.

Authors:  D J Selkoe
Journal:  Neuron       Date:  1991-04       Impact factor: 17.173

2.  Straight and paired helical filaments in Alzheimer disease have a common structural unit.

Authors:  R A Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

3.  Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons.

Authors:  S J Pleasure; C Page; V M Lee
Journal:  J Neurosci       Date:  1992-05       Impact factor: 6.167

4.  Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections.

Authors:  R L Hamilton; J S Wong; L S Guo; S Krisans; R J Havel
Journal:  J Lipid Res       Date:  1990-09       Impact factor: 5.922

5.  Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid.

Authors:  T Wisniewski; B Frangione
Journal:  Neurosci Lett       Date:  1992-02-03       Impact factor: 3.046

6.  Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

Authors:  Y Namba; M Tomonaga; H Kawasaki; E Otomo; K Ikeda
Journal:  Brain Res       Date:  1991-02-08       Impact factor: 3.252

Review 7.  Apolipoprotein E: far more than a lipid transport protein.

Authors:  R W Mahley; S C Rall
Journal:  Annu Rev Genomics Hum Genet       Date:  2000       Impact factor: 8.929

8.  Immunocytochemical properties of Alzheimer straight filaments.

Authors:  G Perry; P Mulvihill; V Manetto; L Autilio-Gambetti; P Gambetti
Journal:  J Neurosci       Date:  1987-11       Impact factor: 6.167

9.  Alzheimer pathology of patients carrying apolipoprotein E epsilon 4 allele.

Authors:  O Heinonen; M Lehtovirta; H Soininen; S Helisalmi; A Mannermaa; H Sorvari; O Kosunen; L Paljärvi; M Ryynänen; P J Riekkinen
Journal:  Neurobiol Aging       Date:  1995 Jul-Aug       Impact factor: 4.673

Review 10.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.

Authors:  R W Mahley
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

View more
  146 in total

1.  PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke.

Authors:  Estelle Rousselet; Jadwiga Marcinkiewicz; Jasna Kriz; Ann Zhou; Mary E Hatten; Annik Prat; Nabil G Seidah
Journal:  J Lipid Res       Date:  2011-04-25       Impact factor: 5.922

Review 2.  Cellular models for tau filament assembly.

Authors:  Li-wen Ko; Michael DeTure; Naruhiko Sahara; Rifki Chihab; Shu-Hui Yen
Journal:  J Mol Neurosci       Date:  2002-12       Impact factor: 3.444

3.  Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.

Authors:  Jon B Toledo; Henrik Zetterberg; Argonde C van Harten; Lidia Glodzik; Pablo Martinez-Lage; Luisella Bocchio-Chiavetto; Lorena Rami; Oskar Hansson; Reisa Sperling; Sebastiaan Engelborghs; Ricardo S Osorio; Hugo Vanderstichele; Manu Vandijck; Harald Hampel; Stefan Teipl; Abhay Moghekar; Marilyn Albert; William T Hu; Jose A Monge Argilés; Ana Gorostidi; Charlotte E Teunissen; Peter P De Deyn; Bradley T Hyman; Jose L Molinuevo; Giovanni B Frisoni; Gurutz Linazasoro; Mony J de Leon; Wiesje M van der Flier; Philip Scheltens; Kaj Blennow; Leslie M Shaw; John Q Trojanowski
Journal:  Brain       Date:  2015-07-27       Impact factor: 13.501

4.  Tryptamine induces tryptophanyl-tRNA synthetase-mediated neurodegeneration with neurofibrillary tangles in human cell and mouse models.

Authors:  Elena L Paley; Galina Denisova; Olga Sokolova; Natalia Posternak; Xukui Wang; Anna-Liisa Brownell
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

5.  The efficiency of protein compartmentalization into the secretory pathway.

Authors:  Corinna G Levine; Devarati Mitra; Ajay Sharma; Carolyn L Smith; Ramanujan S Hegde
Journal:  Mol Biol Cell       Date:  2004-10-20       Impact factor: 4.138

6.  Protection from cytosolic prion protein toxicity by modulation of protein translocation.

Authors:  Neena S Rane; Jesse L Yonkovich; Ramanujan S Hegde
Journal:  EMBO J       Date:  2004-11-04       Impact factor: 11.598

7.  Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity.

Authors:  Shengjun Chang; Tian ran Ma; R Dennis Miranda; Maureen E Balestra; Robert W Mahley; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

8.  Human apolipoprotein E4 worsens acute axonal pathology but not amyloid-β immunoreactivity after traumatic brain injury in 3xTG-AD mice.

Authors:  Rachel E Bennett; Thomas J Esparza; Hal A Lewis; Eddie Kim; Christine L Mac Donald; Patrick M Sullivan; David L Brody
Journal:  J Neuropathol Exp Neurol       Date:  2013-05       Impact factor: 3.685

9.  GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice.

Authors:  Gang Li; Nga Bien-Ly; Yaisa Andrews-Zwilling; Qin Xu; Aubrey Bernardo; Karen Ring; Brian Halabisky; Changhui Deng; Robert W Mahley; Yadong Huang
Journal:  Cell Stem Cell       Date:  2009-12-04       Impact factor: 24.633

Review 10.  Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight.

Authors:  Yang Shi; David M Holtzman
Journal:  Nat Rev Immunol       Date:  2018-12       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.